| Literature DB >> 32398061 |
Mojeed Akorede Gbadamosi1, Boikhutso Tlou2.
Abstract
BACKGROUND: Four major non-communicable diseases (NCD), including T2DM, contributed to nearly three-quarters of all deaths worldwide in 2017. Dietary and lifestyle actors associated with NCDs are potentially modifiable. Therefore, this study was conducted to determine the dietary and lifestyle factors associated with T2DM, pre-diabetes, and hypertension among adult outpatients in Manzini, Swaziland.Entities:
Keywords: Diabetes; Hypertension; Non-communicable diseases; Out-patients; Pre-diabetes; Risk factors; Swaziland; T2DM
Year: 2020 PMID: 32398061 PMCID: PMC7216325 DOI: 10.1186/s12889-020-08816-0
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Characteristics of the study population according to glucose metabolism status and gender
| Men ( | Women ( | |||||||
|---|---|---|---|---|---|---|---|---|
| Normal n (%) | Pre-diabetes n (%) | T2DM a n (%) | Normal n (%) | Pre-diabetes n (%) | T2DM n(%) | |||
| n (%) | 177 (46.0) | 14 (3.6) | 6 (1.6) | 155 (40.3) | 11 (2.8) | 22 (5.7) | ||
| 35.76 (15.43) | 41.36 (15.92) | 46.00 (18.52) | 0.138 | 37.53(14.51) | 51.18 (18.26) | 44.50 (18.48) | 0.004** | |
| 0.247 | 0.062 | |||||||
| 18–27 | 63 (92.6) | 4 (5.9) | 1 (1.5) | 46 (86.8) | 2 (3.8) | 5 (9.4) | ||
| 28–37 | 55 (93.2) | 3 (5.1) | 1 (1.7) | 39 (92.9) | 0 (0.0) | 3 (7.1) | ||
| 38–47 | 24 (88.9) | 1 (3.7) | 2 (7.4) | 37 (84.1) | 1 (2.3) | 6 (13.6) | ||
| 48–57 | 11 (78.6) | 3 (21.4) | 0 (0.0) | 15 (68.2) | 4 (18.2) | 3 (13.6) | ||
| 58–67 | 12 (75.0) | 3 (18.8) | 1 (6.2) | 12 (70.6) | 2 (11.8) | 3 (17.6) | ||
| ≥ 68 | 12 (92.3) | 0 (0.0) | 1 (7.7) | 6 (60.0) | 2 (20.0) | 2 (20.0) | ||
| 0.334 | 0.248 | |||||||
| Normal | 62 (91.2) | 3 (4.4) | 3 (4.4) | 65 (87.5) | 1 (1.4) | 8 (10.8) | ||
| Elevated (Pre-hypertension) | 30 (90.9) | 2 (6.1) | 1 (3.0) | 21 (87.5) | 1 (4.2) | 2 (8.3) | ||
| Stage 1 | 59 (93.7) | 3 (4.8) | 1 (1.6) | 38 (76.0) | 6 (12.0) | 6 (12.0) | ||
| Stage 2 | 26 (78.8) | 6 (18.2) | 1 (3.0) | 31 (77.5) | 3 (7.5) | 6 (15.0) | ||
| 0.171 | 0.398 | |||||||
| Underweight | 18 (94.7) | 1 (5.3) | 0 (0.0) | 2 (100.0) | 0 (0.0) | 0 (0.0) | ||
| Normal | 117 (92.1) | 5 (4.0) | 4 (3.2) | 53 (88.3) | 1 (1.7) | 6 (10.0) | ||
| Overweight | 31 (79.5) | 6 (15.4) | 2 (5.1) | 49 (77.8) | 4 (6.3) | 10 (15.9) | ||
| Obese | 11 (84.6) | 2 (15.4) | 0 (0.0) | 51 (81.0) | 6 (9.5) | 6 (9.5) | ||
| 0.121 | 0.224 | |||||||
| Normal | 156 (90.7) | 10 (5.8) | 6 (3.5) | 43 (89.6) | 1 (2.1) | 4 (8.3) | ||
| ≥ 94 cm (men)/≥80 cm (women) | 21 (84.0) | 4 (16.0) | 0 (0.0) | 112 (80.0) | 10 (7.1) | 18 (12.9) | ||
| 0.069 | 0.832 | |||||||
| Normal | 164 (91.6) | 11 (6.1) | 4 (2.2) | 51 (83.6) | 4 (6.6) | 6 (9.8) | ||
| ≥ 0.95 (men)/≥0.80 (women) | 13 (72.2) | 3 (16.7) | 2 (11.1) | 104 (81.9) | 7 (5.5) | 16 (12.6) | ||
| 0.547 | 0.220 | |||||||
| No formal education | 9 (81.8) | 2 (18.2) | 0 (0.0) | 10 (66.7) | 2 (13.3) | 3 (20.0) | ||
| Primary | 39 (86.7) | 4 (8.9) | 2 (4.4) | 39 (76.8) | 3 (5.9) | 9 (17.6) | ||
| Secondary or higher | 129 (91.5) | 8 (5.7) | 4 (2.8) | 106 (86.9) | 6 (4.9) | 10 (8.2) | ||
| 0.248 | 0.487 | |||||||
| Lower | 55 (87.3) | 5 (7.9) | 3 (4.8) | 50 (78.1) | 3 (4.7) | 11 (17.2) | ||
| Middle | 68 (95.8) | 2 (2.8) | 1 (1.4) | 51 (86.4) | 4 (6.8) | 4 (6.8) | ||
| Higher | 54 (85.7) | 7 (11.1) | 2 (3.2) | 54 (83.1) | 4 (6.2) | 7 (10.8) | ||
| 0.937 | 0.866 | |||||||
| No | 84 (90.3) | 6 (6.5) | 3 (3.2) | 107 (82.3) | 7 (5.4) | 16 (12.3) | ||
| Yes | 93 (89.4) | 8 (7.7) | 3 (2.9) | 48 (82.8) | 4 (6.9) | 6 (10.3) | ||
| 0.022* | 0.001* | |||||||
| No | 91 (95.8) | 3 (3.2) | 1 (1.1) | 89 (89.0) | 0 (0.0) | 11 (11.0) | ||
| Yes | 86 (84.3) | 11 (10.8) | 5 (4.9) | 66 (75.0) | 11 (12.5) | 11 (12.5) | ||
| 0.740 | 0.570 | |||||||
| No | 68 (91.6) | 4 (5.4) | 2 (2.7) | 60 (85.7) | 4 (5.7) | 6 (8.6) | ||
| Yes | 109 (88.6) | 10 (8.1) | 4 (3.3) | 95 (80.5) | 7 (5.9) | 16 (13.6) | ||
a T2DM, Type 2 diabetes mellitus.
b SD, Standard deviation.
**p < 0.05 according to univariate ANOVA
* p < 0.05 according to chi square Pearson statistic or Likelihood ratio
n Number
Gender distribution of study participants and prevalence of raised blood pressure
| Men ( | Women ( | |||||||
|---|---|---|---|---|---|---|---|---|
| Normal n (%) | Elevated BP n (%) | HTN n (%) | Normal n (%) | Elevated BP n (%) | HTN n (%) | |||
| n (%) | 68 (17.7) | 33 (8.6) | 96 (24.9) | 74 (19.2) | 24 (6.2) | 74 (19.2) | ||
| 31.79 (13.08) | 32.70 (15.83) | 41.07 (16.03) | < 0.0001** | 34.12 (12.54) | 34.42 (13.14) | 44.53 (16.79) | < 0.0001** | |
| 0.006* | 0.005* | |||||||
| 18–27 | 32 (47.1) | 15 (22.1) | 21 (30.9) | 27 (50.9) | 10 (18.9) | 16 (30.2) | ||
| 28–37 | 21 (35.6) | 9 (15.3) | 29 (49.2) | 22 (52.4) | 5 (11.9) | 15 (35.7) | ||
| 38–47 | 7 (25.9) | 4 (14.8) | 16 (59.3) | 14 (31.8) | 5 (11.4) | 25 (56.8) | ||
| 48–57 | 3 (21.4) | 2 (14.3) | 9 (64.3) | 7 (31.8) | 2 (9.1) | 13 (59.1) | ||
| 58–67 | 4 (25.0) | 0 (0.0) | 12 (75.0) | 3 (17.6) | 2 (11.8) | 12 (70.6) | ||
| ≥ 68 | 1 (7.7) | 3 (23.1) | 9 (61.2) | 1 (10.0) | 0 (0.0) | 9 (90.0) | ||
| 0.010* | 0.008* | |||||||
| Underweight | 11 (57.9) | 1 (5.3) | 7 (36.8) | 1 (50.0) | 0 (0.0) | 1 (50.0) | ||
| Normal | 46 (36.5) | 26 (20.6) | 54 (42.9) | 35 (58.3) | 7 (11.7) | 18 (30.0) | ||
| Overweight | 10 (25.6) | 4 (10.3) | 25 (64.1) | 22 (34.9) | 6 (9.5) | 35 (55.6) | ||
| Obese | 1 (7.7) | 2 (15.4) | 10 (76.9) | 16 (25.4) | 11 (17.5) | 36 (57.1) | ||
| 0.016* | 0.005* | |||||||
| Normal | 65 (37.8) | 29 (16.9) | 78 (45.3) | 28 (58.3) | 6 (12.5) | 14 (29.2) | ||
| ≥ 94 cm (men)/≥80 cm (women) | 3 (12.0) | 4 (16.0) | 18 (72.0) | 46 (32.9) | 18 (12.9) | 76 (54.3) | ||
| 0.738 | 0.810 | |||||||
| Normal | 63 (35.2) | 29 (16.2) | 29 (16.2) | 22 (36.1) | 8 (13.1) | 31 (50.8) | ||
| ≥ 0.95 (men)/≥0.80 (women) | 5 (27.8) | 5 (27.8) | 4 (22.2) | 52 (40.9) | 16 (12.6) | 59 (46.5) | ||
| 0.100 | 0.112 | |||||||
| No formal education | 2 (18.2) | 3 (27.3) | 6 (54.5) | 4 (26.7) | 1 (6.7) | 10 (66.7) | ||
| Primary | 21 (46.7) | 3 (6.7) | 21 (46.7) | 17 (33.3) | 4 (7.8) | 30 (58.8) | ||
| Secondary or higher | 45 (31.9) | 27 (19.1) | 69 (48.9) | 53 (43.4) | 19 (15.6) | 50 (41.0) | ||
| 0.388 | 0.289 | |||||||
| Lower | 25 (39.7) | 12 (19.0) | 26 (41.3) | 25 (39.1) | 4 (6.2) | 35 (54.7) | ||
| Middle | 23 (32.4) | 14 (19.7) | 34 (47.9) | 25 (42.4) | 8 (13.6) | 26 (44.1) | ||
| Higher | 20 (31.7) | 7 (11.1) | 36 (57.1) | 24 (36.9) | 12 (18.5) | 29 (44.6) | ||
| 0.740 | 0.582 | |||||||
| No | 30 (32.3) | 15 (16.1) | 48 (51.6) | 54 (41.5) | 15 (11.5) | 61 (46.9) | ||
| Yes | 38 (36.5) | 18 (17.3) | 48 (46.2) | 20 (34.5) | 9 (15.5) | 61 (46.9) | ||
| 0.996 | 0.542 | |||||||
| No | 33 (34.7) | 16 (16.8) | 46 (48.4) | 40 (40.0) | 15 (15.0) | 45 (45.0) | ||
| Yes | 35 (34.3) | 17 (16.7) | 50 (49.0) | 34 (38.6) | 9 (10.2) | 45 (51.1) | ||
| 0.240 | 0.395 | |||||||
| No | 31 (41.9) | 11 (14.9) | 32 (43.2) | 31 (44.3) | 10 (14.3) | 29 (41.4) | ||
| Yes | 37 (30.1) | 22 (17.9) | 64 (52.0) | 43 (36.4) | 14 (11.9) | 61 (51.7) | ||
HTN Hypertension; n Number; SD Standard deviation; *p < 0.05 according to Pearson or Likelihood ration chi square; **p < 0.05 according to Univariate ANOVA.
Crude and adjusted odds ratios for risk factors associated with pre-diabetes and T2DM
| Pre-diabetes | T2DM | |||||||
|---|---|---|---|---|---|---|---|---|
| COR | 95% CI | AOR | 95% CI | COR | 95% CI | AOR | 95% CI | |
| No formal education | 1 | 1 | ||||||
| Primary | 0.426 | 0.11–1.61 | 0.893 | 0.23–3.52 | ||||
| Secondary or higher | 0.283* | 0.09–0.95 | 0.377 | 0.10–1.43 | ||||
| Lower | 1 | 1 | ||||||
| Middle | 0.662 | 0.22–1.97 | 0.315* | 0.11–0.90 | ||||
| Higher | 1.337 | 0.52–3.46 | 0.625 | 0.26–1.51 | ||||
| No | 1 | 1 | ||||||
| Yes | 1.250 | 0.55–2.82 | 0.642 | 0.28–1.46 | ||||
| No | 1 | 1 | 1 | |||||
| Yes | 8.684*** | 2.55–29.58 | 8.895* | 2.27–34.82 | 1.579 | 0.73–3.44 | ||
| No | 1 | 1 | ||||||
| Yes | 1.333 | 0.56–3.18 | 1.569 | 0.67–3.67 | ||||
| No | 1 | 1 | 1 | 1 | ||||
| Yes | 2.516 | 0.98–6.46 | 3.479* | 1.08–11.65 | 1.986 | 0.85–4.64 | 3.185* | 1.04–4.75 |
| No | 1 | 1 | 1 | |||||
| Yes | 4.048* | 1.48–11.04 | 8.434** | 2.50–28.48 | 7.01* | 1.77–5.72 | ||
| No | 1 | 1 | 1 | 1 | ||||
| Yes | 0.206*** | 0.09–0.48 | 0.261* | 0.09–0.76 | 0.122*** | 0.05–0.30 | 0.120*** | 0.04–0.38 |
| No | 1 | 1 | 1 | 1 | ||||
| Yes | 0.048*** | 0.02–0.14 | 0.048*** | 0.02–0.15 | 0.032*** | 0.01–0.10 | 0.047*** | 0.01–0.16 |
AOR Adjusted odds ratio; 95% CI 95% Confidence interval; COR Crude odds ratio; SES Socio-economic status.
a Participants meet the WHO recommended physical activity per week.
*P < 0.05, **P < 0.001, ***P < 0.0001
Crude and adjusted odds ratio of factors associated with elevated BP and hypertension
| Prehypertension | Hypertension | |||||||
|---|---|---|---|---|---|---|---|---|
| COR | 95% CI | AOR | 95% CI | COR | 95% CI | AOR | 95% CI | |
| No formal education | 1 | 1 | 1 | |||||
| Primary | 0.276 | 0.06–1.24 | 0.284 | 0.06–1.27 | 0.503 | 0.18–1.41 | ||
| Secondary or higher | 0.704 | 0.19–2.62 | 0.711 | 0.19–2.64 | 0.455 | 0.17–1.21 | ||
| Lower | 1 | 1 | ||||||
| Middle | 1.432 | 0.67–3.05 | 1.025 | 0.60–1.75 | ||||
| Higher | 1.349 | 0.62–2.94 | 1.211 | 0.71–2.07 | ||||
| No | 1 | 1 | ||||||
| Yes | 1.303 | 0.70–2.42 | 1.023 | 0.65–1.60 | ||||
| No | 1 | 1 | ||||||
| Yes | 0.887 | 0.48–1.64 | 1.104 | 0.71–1.71 | ||||
| No | 1 | 1 | ||||||
| Yes | 1.329 | 0.71–2.50 | 1.588* | 1.01–2.49 | ||||
| No | 1 | 1 | ||||||
| Yes | 0.993 | 0.54–1.84 | 1.624* | 1.04–2.54 | ||||
| No | 1 | 1 | 1 | |||||
| Yes | 0.672 | 0.36–1.26 | 2.248*** | 1.44–3.52 | 2.100* | 1.32–3.34 | ||
| No | 1 | 1 | ||||||
| Yes | 1.040 | 0.53–2.06 | 0.688 | 0.43–1.10 | ||||
| No | 1 | 1 | 1 | |||||
| Yes | 0.941 | 0.40–2.20 | 0.368*** | 0.21–0.64 | 0.422* | 0.24–0.75 | ||
AOR Adjusted odds ratio; 95% CI, 95% Confidence interval; COR Crude odds ratio; SES Socio-economic status.
a Participants meet the WHO recommended physical activity per week.
*P < 0.05, **P < 0.001, ***P < 0.0001
Backward conditional.